If MHRA approval arrives in late 2027 to mid-2028, private availability could follow within weeks, as it did with Mounjaro and Wegovy
These weight loss methods continue to help millions of people worldwide lose weight
Effect of once-weekly semaglutide on the counterregulatory response to hypoglycaemia in People with type 2 diabetes: a randomized, placebo-controlled, double-blind, crossover trial
From the sudden shutdown of Peptide Sciences to upcoming regulatory changes and the future of GLP-1 compounds like Retatrutide, this episode dives deep into the evolving landscape of peptides and what it could mean for consumers moving forward
Its not clear what initial dose means, as it implies only the first month will be priced at such a discount
How do I track my weight on GLP-1 medications